Characterization and clinical evaluation of CD10+ stroma cells in the breast cancer microenvironment.
about
Mesenchymal precursor cells maintain the differentiation and proliferation potentials of breast epithelial cells.Identification of novel low-dose bisphenol a targets in human foreskin fibroblast cells derived from hypospadias patientsTransfer of clinically relevant gene expression signatures in breast cancer: from Affymetrix microarray to Illumina RNA-Sequencing technology.Constitutive phosphorylated STAT3-associated gene signature is predictive for trastuzumab resistance in primary HER2-positive breast cancer.CD10 Positive Recurrent Undifferentiated Mammary Sarcoma in a Young Female: A Rare Case Report with Brief Review of Literature.Tumoral CD10 expression correlates with aggressive histology and prognosis in patients with malignant pleural mesothelioma.CD10-Equipped Melanoma Cells Acquire Highly Potent Tumorigenic Activity: A Plausible Explanation of Their Significance for a Poor PrognosisTumoral CD10 expression correlates with high-grade histology and increases risk of recurrence in patients with stage I lung adenocarcinomaIdentification of stromal ColXα1 and tumor-infiltrating lymphocytes as putative predictive markers of neoadjuvant therapy in estrogen receptor-positive/HER2-positive breast cancerSignatures of tumor-immune interactions as biomarkers for breast cancer prognosisWhole transcriptome profiling of patient-derived xenograft models as a tool to identify both tumor and stromal specific biomarkersCan stroma reaction predict cancer lethality?Tumor-stromal interactions in breast tumor progression--significance of histological heterogeneity of tumor-stromal fibroblasts.Crosstalk between breast cancer stem cells and metastatic niche: emerging molecular metastasis pathway?The past and future of breast cancer treatment-from the papyrus to individualised treatment approaches.Personalized therapy for breast cancer: a dream or a reality?Gene expression information improves reliability of receptor status in breast cancer patients.Stromal CD10 expression in breast cancer correlates with tumor invasion and cancer stem cell phenotype.
P2860
Q33892347-D3BF505D-6F70-45E0-9DFE-A491BB24AEDFQ34264912-1D9EA878-CC2A-4F2A-8E53-CE0809F6FE8BQ34897615-7BBD0555-D7D0-468C-ABBB-DA5935B2E149Q35733734-CCC3CADC-D4EC-486B-8AD4-4D9DEA310128Q35869207-6A239E9A-7473-489A-9610-D41D5D4121BEQ35880415-D5C72490-1392-4AD7-B4DC-4AA1F0D24CE8Q35924872-5BF4743B-18FA-4FAF-9F41-D82DC74CD0E7Q35940727-7FB8574A-6B8D-46C7-A37A-A533A59BCA9BQ35992815-A2D57E68-1418-4FC8-9F7C-14CF091AFDCCQ36253304-64DD6712-1BD7-4D62-BD12-90749AE2570DQ37190437-E5265BC2-8F30-4685-9B7E-78AA456EBABCQ37698131-DC93D306-FB80-4C4E-8C60-7AF42FF0EB4AQ38072443-798D0992-B57E-47BA-893A-1DAFA830B8F8Q38107895-681BB5D2-CD0A-4832-ACAB-7BC36F40A5B1Q38660610-E85B328D-5B08-48A2-A402-2D6D342332C1Q39374969-61FC36FA-01D7-4930-AEB5-A969A1F8CB93Q43654815-1C11081D-7E93-4937-9717-2011DBD2B04FQ49188355-7F7155DC-FC88-4BEB-9A5E-AC66ACBD79A2
P2860
Characterization and clinical evaluation of CD10+ stroma cells in the breast cancer microenvironment.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Characterization and clinical ...... reast cancer microenvironment.
@ast
Characterization and clinical ...... reast cancer microenvironment.
@en
type
label
Characterization and clinical ...... reast cancer microenvironment.
@ast
Characterization and clinical ...... reast cancer microenvironment.
@en
prefLabel
Characterization and clinical ...... reast cancer microenvironment.
@ast
Characterization and clinical ...... reast cancer microenvironment.
@en
P2093
P2860
P50
P1476
Characterization and clinical ...... reast cancer microenvironment.
@en
P2093
Carole Chaboteaux
Christos Sotiriou
Cédric Blanpain
Denis Larsimont
Fabrice Journe
Frank El Ouriaghli
Françoise Lallemand
Hughes Duvillier
Laurence Lagneaux
Martine Piccart
P2860
P304
P356
10.1158/1078-0432.CCR-11-0383
P407
P577
2012-01-10T00:00:00Z